Clinical Trials on Exercise Intolerance in Russian Federation

Total 12 results

Research Institute for Complex Problems of Cardiovascular...

Unknown

Prehabilitation for Cardiac Surgery in Patients With Reduced Exercise Tolerance

Heart Failure | Sarcopenia | Peripheral Artery Disease | Exercise Intolerance

Russian Federation
I.M. Sechenov First Moscow State Medical University

Completed

Direct and Cross Effects of Adaptation to Systemic Hyperthermia: Impact on Quality of Life, Neurohormonal and Psychophysiological Human Status

Quality of Life | Metabolic Disturbance | Exercise Tolerance | Hypoxia, Altitude

Russian Federation
I.M. Sechenov First Moscow State Medical University

Enrolling by invitation

Diagnostics of Coronavirus Disease 2019 Cardiovascular Complications

COVID-19 | Quality of Life | Oxygen Consumption | Diastolic Dysfunction | Endothelial Function | Exercise Tolerance

Russian Federation
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Subetta in the Treatment of Impaired Glucose Tolerance

Impaired Glucose Tolerance

Russian Federation
I.M. Sechenov First Moscow State Medical University

Recruiting

Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection.

COVID-19 | Quality of Life | Hypertension | Arrhythmia | Chronic Heart Failure | Endothelial Dysfunction | Conduct Disorder | Oxygen Consumption | Diastolic Dysfunction | Chronic Coronary Syndrome | Exercise Tolerance

Russian Federation
Federal State Budgetary Institution, V. A. Almazov...

Completed

Spinal Cord Stimulation for Orthostatic Hypotension

Orthostatic Hypotension

Russian Federation
AstraZeneca

Recruiting

A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma (BREATH)

Asthma, Exercise-Induced

Russian Federation
Valexfarm

Completed

Remegal Different Doses in Patients With Refractory Partial Seizures

Self Efficacy | Drug Safety | Normal Drug Tolerance

Russian Federation
Boehringer Ingelheim
Pfizer

Completed

Tiotropium In Exercise

Pulmonary Disease, Chronic Obstructive | Exercise

United States, Argentina, Brazil, Canada, Germany, Italy, Portugal, Russian Federation, Spain, Taiwan, Ukraine
Theravance Biopharma

Terminated

Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure (OAK)

Symptomatic Neurogenic Orthostatic Hypotension

United States, Spain, Portugal, United Kingdom, France, Denmark, Ukraine, Israel, Estonia, Poland, Italy, Russian Federation, Australia, Austria, Bulgaria, Canada, Germany, New Zealand
Theravance Biopharma

Completed

Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure (SEQUOIA)

Symptomatic Neurogenic Orthostatic Hypotension

United States, Spain, Israel, Hungary, Portugal, Australia, Canada, Germany, Russian Federation, Estonia, France, Italy, United Kingdom, Denmark, Poland, New Zealand, Austria, Bulgaria, Ukraine
Theravance Biopharma

Terminated

Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure (REDWOOD)

Parkinson's Disease (PD) | MSA | Symptomatic Neurogenic Orthostatic Hypotension | Pure Autonomic Failure (PAF)

United States, Spain, United Kingdom, Canada, France, Estonia, Australia, Israel, Denmark, Italy, Poland, New Zealand, Germany, Ukraine, Austria, Bulgaria, Portugal, Hungary, Russian Federation

Clinical Trials on Exercise Intolerance in Russian Federation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations